Market Research Logo

Global Active Pharmaceuticals Ingredients Market - Segmented by Business mode, Synthesis Type, Customer Base, Therapeutic Area, And Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Active Pharmaceuticals Ingredients Market - Segmented by Business mode, Synthesis Type, Customer Base, Therapeutic Area, And Geography - Growth, Trends, and Forecast (2018 - 2023)

The global active pharmaceutical ingredients market is expected to register a CAGR of approximately 6.2% during the forecast period (2018 - 2023). Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. The expenditure on research & development, favorable government initiatives, and high technological advancements makes North America the dominant market in the forecast period.

Rising Demand for Generic Drugs

Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. It has been estimated that generic drugs save approximately USD 3 billion every week in the United States. In 2013, unbranded generic drugs accounted for more than 80% of the prescription drugs being distributed, primarily due to their low price for patients, payers, and the healthcare system. Therefore, the rise in the demand for generic drugs is expected to be one of the major drivers for the API market.

Other factors playing a vital role for the growth of this market include the rise in the geriatric population with an increase in chronic and lifestyles related disorders, technological advancements in the process of API manufacture, and rising preference for targeted therapy approach in cancer treatment.

Stringent Regulatory Framework

One of the major factors acting as an obstacle is the stringent regulatory framework across several regions. Moreover, the differences in the regulatory requirements in each country have made this an extremely complex market in the recent times. With European Union, several other countries are adopting fierce regulatory requirements and enforcing API inspection system similar to the level of FDA. This is a step towards standardized regulatory framework globally. These factors restrict the growth of companies in many regions and hinder the growth of this market.

Furthermore, other factors such as large capital investment, production cost, as well as variable drug price control policies hamper the growth of this market.

Asia-Pacific Expected to Register a High Growth Rate

The Asia-Pacific is expected to register a high growth rate compared to other regions during the forecast period, owing to the factors such as increasing healthcare expenditures, growing aging population creating a huge patient pool, and rising economies in this region.

Key Developments in the Market

  • February 2018: ACETO Corporation with Rising Pharmaceuticals launched Atenolol tablets, 25mg, 50mg, and 100mg for hypertension.
  • February 2018: Novo Nordisk invested an additional USD 65 million into the plant established in Clayton, North Carolina for building a USD 2 billion API facility there.
  • January 2018: Sterling Pharma Solutions expanded its presence in the Asia region with growth experienced in the Japanese API market.
Major players: ABBOTT LABORATORIES, BOEHRINGER INGELHEIM, BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, JOHNSON & JOHNSON, MERCK & CO., INC, NOVARTIS INTERNATIONAL AG, ROCHE HOLDING AG, SANOFI SA, AND TEVA PHARMACEUTICAL INDUSTRIES LTD, among others.

Reasons to Purchase this Report
  • Current and future of global active pharmaceutical ingredients market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Analysis on the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Degree of Competition
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Huge Impact from Pharmaceutical Industry
6.1.2 Increasing Adoption of Biologicals and Biosimilars
6.1.3 Rising Prevalence of Cancer
6.2 Market Restraints
6.2.1 Drug Price Control Policies Across Various Countries
6.2.2 Fierce Competition Between the API Manufacturers
6.2.3 Stringent Regulations
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Business Mode
7.1.1 Captive Active Pharmaceutical Ingredients (API)
7.1.2 Merchant Active Pharmaceutical Ingredients (API)
7.2 By Type of Synthesis
7.2.1 Synthetic
7.2.2 Biotech
7.3 By Customer Base
7.3.1 Generic
7.3.2 Branded
7.4 By Application
7.4.1 Cardiology
7.4.2 Pulmonology
7.4.3 Oncology
7.4.4 Ophthalmology
7.4.5 Neurology
7.4.6 Orthopedics
7.5 By Geography
7.5.1 North America
7.5.1.1 United states
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 France
7.5.2.2 United kingdom
7.5.2.3 Germany
7.5.2.4 Spain
7.5.2.5 Italy
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 India
7.5.3.2 China
7.5.3.3 Japan
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of Asia-Pacific
7.5.4 Middle East Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Albemarle Corporation
9.2 Aurobindo pharma
9.3 Boehringer Ingelheim GmbH
9.4 Dr. Reddy's Lab
9.5 Lupin
9.6 Mylan N.V
9.7 Novartis
9.8 Pfizer, Inc
9.9 Ranbaxy Laboratories
9.10 Teva Active Pharmaceutical Industries Limited
10. Future Market Outlook

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report